Diagnostics (Jun 2022)

Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions

  • Michela Gravina,
  • Lorenzo Spirito,
  • Giuseppe Celentano,
  • Marco Capece,
  • Massimiliano Creta,
  • Gianluigi Califano,
  • Claudia Collà Ruvolo,
  • Simone Morra,
  • Massimo Imbriaco,
  • Francesco Di Bello,
  • Antonio Sciuto,
  • Renato Cuocolo,
  • Luigi Napolitano,
  • Roberto La Rocca,
  • Vincenzo Mirone,
  • Carlo Sansone,
  • Nicola Longo

DOI
https://doi.org/10.3390/diagnostics12071565
Journal volume & issue
Vol. 12, no. 7
p. 1565

Abstract

Read online

The Prostate Imaging Reporting and Data System (PI-RADS) classification is based on a scale of values from 1 to 5. The value is assigned according to the probability that a finding is a malignant tumor (prostate carcinoma) and is calculated by evaluating the signal behavior in morphological, diffusion, and post-contrastographic sequences. A PI-RADS score of 3 is recognized as the equivocal likelihood of clinically significant prostate cancer, making its diagnosis very challenging. While PI-RADS values of 4 and 5 make biopsy necessary, it is very hard to establish whether to perform a biopsy or not in patients with a PI-RADS score 3. In recent years, machine learning algorithms have been proposed for a wide range of applications in medical fields, thanks to their ability to extract hidden information and to learn from a set of data without previous specific programming. In this paper, we evaluate machine learning approaches in detecting prostate cancer in patients with PI-RADS score 3 lesions via considering clinical-radiological characteristics. A total of 109 patients were included in this study. We collected data on body mass index (BMI), location of suspicious PI-RADS 3 lesions, serum prostate-specific antigen (PSA) level, prostate volume, PSA density, and histopathology results. The implemented classifiers exploit a patient’s clinical and radiological information to generate a probability of malignancy that could help the physicians in diagnostic decisions, including the need for a biopsy.

Keywords